Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tetratricopeptide repeat protein 12 (TTC12) is a cytoplasmic protein containing three tetratricopeptide repeat (TPR) domains in its N-terminal region and three armadillo repeat domains in its C-terminal region[2][3][6]. TTC12 plays a critical role in the assembly of axonemal dynein arm complexes in motile cilia and sperm flagella, and is implicated in the correct functioning of these structures in respiratory and reproductive tissues[2][3][6][7]. Mutations in TTC12 cause a subset of primary ciliary dyskinesia (PCD), producing defects in dynein arms of both cilia and flagella, manifesting clinically as chronic respiratory infections and male infertility due to impaired sperm motility[2][3]. TTC12 is not classically regarded as a drug target (no approved drugs or targeted therapies are known), but it is a functionally significant gene for genetic and rare disease research, specifically in the study of ciliary disorders[2][3][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tetratricopeptide repeat protein 12 (TTC12).